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Abstract
Objectives—Florida has the second highest incidence of melanoma in the United States, and
more than 600 Floridians die from melanoma annually. Given the lack of population-based data on
skin cancer screening among the different US geographic regions, we compared skin cancer
screening rates among Floridians to those in the rest of the South, the Northeast, the Midwest, and
the West.
Methods—We used data from the 2000 and 2005 National Health Interview Survey. Data were
grouped according to whether participants reported ever receiving a skin cancer examination in
their lifetime. Data were pooled, and analyses accounted for sample weights and design effects.
Multivariable logistic regression analyses were performed with self-reported skin screening as the
outcome of interest.
Results—Results showed that compared to the rest of the US, Floridians who were women 70
years old and older, reported being of “other” race, of non-Hispanic ethnicity, having a high
school education, having health insurance, and employed in the service industry or unemployed,
had significantly higher lifetime skin cancer screening rates than their subgroup counterparts
residing in the other regions. Multivariable logistic regression showed that Floridians remained
significantly more likely to have ever been screened for skin cancer compared to the other US
regions after controlling for a variety of sociodemographic variables.
Conclusions—Increasing melanoma detection remains a national cancer goal for the US, and
future identification of underlying causal factors for higher screening rates in Florida could inform
intervention strategies in the other US regions.
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Florida has the second highest incidence of melanoma in the United States, with an
estimated 5260 new cases in 2011.1 More than 600 Floridians die of melanoma every year;
since 1975, the number of deaths among residents older than age 50 has almost doubled.2
Previous studies have found that melanoma rates are highest in men3 and non-Hispanic
whites.4 Melanoma incidence is associated with a variety of socioeconomic indicators such
as higher educational attainment,5 lack of health insurance,6 being a nonsmoker,6 not being
an excessive drinker,6 being physically active,6 and being employed.7 Fortunately, the 5-
year survival rate for individuals whose melanoma is treated before it spreads to the regional
lymph nodes is 98%.1
Skin cancer screening and early detection may be accomplished by a healthcare provider
(clinical examination) or by self-examination. Even though there have been no completed
randomized trials to evaluate the effect of skin screening on melanoma mortality, one case-
control study suggested that skin self-examination may lower melanoma-related mortality.8
In addition, a recent cohort study found that a thorough clinical skin examination increased
the likelihood of identifying suspected melanoma.9 In a published letter, we reported that
Floridians have higher skin cancer screening rates than the rest of the United States, but we
did not investigate regional comparisons within the United States.10 Although Florida has a
very high ultraviolet (UV) light index,11 it is important to focus on skin cancer prevention
efforts in other areas of the US. For example, residents in other southern states also are at
risk for developing melanoma due to high UV exposure.12 Given the amount of ambient
sunlight in Florida11 and the lack of data comparing skin cancer screening rates among the
different US geographic regions, we compared skin cancer screening rates in Florida with
those in the rest of the South, Northeast, Midwest, and West.
Methods
The National Health Interview Survey (NHIS) is an annual, cross-sectional representative
household survey of the US civilian noninstitutionalized population. We analyzed data from
the 2000 and 2005 NHIS Cancer Control Modules (CCMs),13 which are the only source of
national population-based data on cancer screening. CCMs focus on issues pertaining to
knowledge and practices of cancer-related health behaviors. We specifically evaluated
sociodemographic, health, and risk factor data, including age, body mass index, sex,
educational attainment, race, employment, health insurance, and smoking and drinking
status, as well as compliance with Healthy People 2010 recommendations for physical
exercise. In all of the CCMs, participants were asked, “Have you EVER had all of your skin
from head to toe checked for cancer by a dermatologist or some other kind of doctor?” Data
were pooled and analyses took into account sample weights and design effects. Logistic
regression analyses were performed with self-reported lifetime skin screening as the
outcome of interest. In the logistic regression analyses, the corresponding values are odds
ratios (ORs). OR estimates >1 (with the corresponding 95% confidence interval [CI] that
does not include 1) indicate that the odds or risk of screening is statistically higher than the
comparison group of interest. Conversely, ORs <1 (with a corresponding 95% CI that does
not include 1) indicate that the odds of screening are significantly lower than the comparison
group of interest. Florida data were compared with data from the different US geographic
regions, as determined by the NHIS (ie, the rest of the South (not including Florida),
Midwest, West, and Northeast). (For the specific state compositions of each region, see the
US Census Regions and Divisions of the US.14)
Data management and analyses were conducted using SAS statistical software version 9.2
(SAS Institute Inc, Cary, NC), which allows the analysis of weighted, complex sample
survey data and the adjustments for sample weights and design effects. Records from each
survey year were weighted according to person-level weights provided in the annual NHIS
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data files. Weights were adjusted according to the number of representative years used in the
analyses. All of the analyses were conducted at the Research Data Center of the National
Center for Health Statistics to ensure participant confidentiality. The study was approved by
the University of Miami institutional review board.
Results
Overall Sociodemographic Data
Our total sample size was 60,118 and the number of Floridians in our sample was 3963. All
of the demographic variables and prevalence rates are seen in Table 1.
Prevalence Differences between Florida and Rest of South
The sample size of those in the South was 18,034. When compared with the rest of the
South, Floridians reported significantly higher overall skin cancer screening rates in their
lifetime. Floridians aged 30 to 39, 60 to 69, 70 to 79, and 80 years and older reported
significantly higher screening rates than those groups in the rest of the South. Both male and
female Floridians had significantly higher screening rates than those in the rest of the South,
as well as whites, those of “other” race, and non-Hispanics. Regardless of educational
attainment or health insurance status, Floridians had higher screening rates. When broken
down by employment status, Floridians who were employed, unemployed (including
retired), in the service sector, and blue collar workers had significantly higher screening
rates than the rest of the South.
Prevalence Differences between Florida and Northeast
The sample size of those in the Northeast sample was 10,599. Floridian women had
significantly higher screening rates than did those in the Northeast, as did Floridians aged 60
to 69, 70 to 79, and 80 years and older. Floridians who identified as being of “other” race,
non-Hispanic, with a high school education, and with health insurance had significantly
higher screening rates. In addition, people who were unemployed and service workers in
Florida had significantly higher screening rates than those subgroups in the Northeast.
Prevalence Differences between Florida and Midwest
The sample size of those in the Midwest was 14,071. Overall, Floridians had higher
screening rates than did the Midwest, including both men and women. All of the Floridian
age groups had higher rates than those in the Midwest; however, this was not significant in
those 18 to 29 years old. White, “other” race, and non-Hispanic Floridians had significantly
higher rates than these groups in the Midwest, as did Floridians with a high school education
or more. Employed, unemployed, white collar, and service sector Floridians had
significantly higher screening rates than did those in the Midwest.
Prevalence Differences between Florida and West
The sample size of those in the West was 13,451. Overall, Floridians had significantly
higher screening rates than those in the West. Both Floridian men and women had higher
screening rates than those in the West, as did Floridians aged 30 to 39, 70 to 79, and 80
years and older. White, “other” race, non-Hispanics, and Hispanic Floridians had
significantly higher rates. Regardless of educational attainment or health insurance status,
Floridians had higher screening rates than those groups in the West. All occupational groups
in Florida, except white collar and farm workers, had significantly higher screening rates
than those in the West.
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Logistic Regression Comparing Florida to Other US Regions
As presented in Table 2, after controlling for age, body mass index, gender, educational
attainment, race, employment, health insurance, smoking and drinking status, and
compliance with Healthy People 2010 recommendations for physical exercise, all regions
had significantly lower lifetime skin cancer screening rates relative to Florida: South (OR
0.75, 95% CI 0.75–0.75), Northeast (OR 0.84, 95% CI 0.84–0.84), Midwest (OR 0.53, 95%
CI 0.53–0.53), and West (OR 0.74, 95% CI 0.74–0.74).
Discussion
The daily routine of Floridians exposes them to more UV rays than most other people in the
US.11 Increased sun exposure equals an increased risk of developing skin cancer, but it does
not necessarily translate to increased awareness of or participation in cancer screening. Our
results found that compared with the rest of the nation, Floridians who were women older
than 70 years, who reported being of “other” race, of non-Hispanic ethnicity, who had a high
school education, who had health insurance, who were employed in the service industry, or
who were unemployed (including those who are retired) had significantly higher skin cancer
screening rates than their counterparts residing in the rest of the South, the Northeast, the
Midwest, and the West. Even after adjusting for the sociodemographic and health-related
indicators, Floridians retained significantly higher odds of reporting lifetime skin cancer
screening compared with the other regions in the US. The biggest difference found was
between Florida and the Midwest, with Florida having much higher screening rates. This
shows that regional variations in screening rates exist in the US; these results are consistent
with the limited number of previous research studies on this topic15; however, no previous
studies have separated Florida, a state where residents are exposed to high UV rays all year
long, from other distinct US regions to evaluate skin cancer–screening behaviors. It is
important to note that all individuals in the US are exposed to UV rays no matter what their
state of residence. For example, the mean UV index (on a scale of 0–12, 12 being the
highest) for residents living in the rest of the South in July is between 8 and 9.11
The literature has shown that elderly adults bear a disproportionate burden of morbidity and
mortality from melanoma,16 and melanoma incidence is highest in non-Hispanic whites.4
Fortunately, in Florida, these groups reported the highest rates of skin cancer screening
compared with the other US geographic regions. This positive health behavior may be due to
several cancer initiatives in Florida that influence screening activities, which could be
applied to other regions of the country. For example, the American Academy of
Dermatology reports that Florida, compared with all other US states, has the highest number
of free skin cancer screening sites.17 Included in this are the efforts of the Moffitt Cancer
Center and Research Institute’s program, Mole Patrol, which provides free skin cancer
screenings to individuals on Florida’s beaches, and that partners with several other Florida
organizations to increase cancer awareness.18 Florida also has a comprehensive cancer plan,
in which several government-led organizations focus on decreasing the incidence and
mortality of cancer.19
Previous studies have found an association between higher dermatologist densities and
lower melanoma mortality rates, due to greater opportunities for earlier detection.20,21 A
higher density of dermatologists in Florida compared with other states also may help
account for higher screening rates.20,22 Although it is not likely that other regions of the
country can easily change the density of dermatologists within their region, it may be
feasible to offer a greater number of free skin screenings, especially in the context of high-
sun-exposure outdoor activities. Regardless, educational initiatives for both patients and
health practitioners also can highlight the potential benefits and recommendations for skin
cancer screening.
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Consistent with previous studies, skin cancer screening rates have been shown to increase
with a variety of socioeconomic indicators, such as higher educational attainment, health
insurance, physical activity, and low unemployment.15 Therefore, increased targeting for
those of lower socioeconomic status is warranted, particularly for Hispanics and people of
African descent (who often do not believe they are at risk for skin cancer due to their darker
skin tone).23
It is important to note that, to date, the US Preventive Services Task Force has not found
sufficient evidence to make recommendations regarding skin cancer screening24; however,
recent findings from a population-based skin cancer study in Germany strongly suggests that
early detection does save lives.25,26 This screening effort led to the detection of more than
half of the melanomas diagnosed in the Schleswig-Holstein area of Germany. This resulted
in an (expected) increase in melanoma incidence rates,26 but a decline in the age-
standardized melanoma mortality rate by nearly 50%.25 The American Cancer Society
recommends monthly self-examinations and yearly skin examinations by a doctor to detect
skin cancer early and to make it easier to treat.27 The American Academy of Dermatology
and the Centers for Disease Control and Prevention also recommend that “physicians should
examine exposed areas of the skin for cancer whenever the opportunity arises.”28
The limitations of the present study include the cross-sectional nature of the NHIS. Another
limitation is the self-reported nature of the NHIS data, which can limit its validity; however,
a similarly worded question regarding self-reported whole-body skin examination has been
validated with a sensitivity of 90.5, although it is important to note that this study was
conducted outside the United States.29 Also, there is no way to determine who is conducting
the screening, and the literature has shown that screening accuracy varies by the type of
practitioner.24 Finally, it is unknown whether te older participants moved to Florida to retire
or have lived their whole lives in Florida.
The strengths of this study include the use of the NHIS CCMs, which are the only source of
national population-based data on cancer screening.13 In addition, using the NHIS and
conducting analyses at the Research Data Center allowed for large sample sizes and the
ability to compare Florida to the different geographic regions of the US.
Conclusions
In summary, living in the “Sunshine State” may raise awareness of the need for skin cancer
screening, especially among individuals who are most at risk for melanoma. The results
provided in the present study could be used by public health officials in other states, with the
support of primary care physicians and other health care providers, to develop and
implement local community health fairs specifically targeting the delivery of mass screening
programs. This is particularly important for high-risk groups reporting low skin examination
rates. In addition, other states with a high UV index (eg, the rest of the South) should
develop targeted public health initiatives for their states. Increasing the early detection and
prevention of melanoma remains a national cancer goal for the United States, especially in
areas with a high UV index.
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• There is a lack of population-based data on skin cancer screening among the
different US geographic regions.
• Multivariable logistic regression showed that Floridians remained significantly
more likely to have ever been screened for skin cancer compared to other US
geographic regions.
• The identification of underlying causal factors for higher screening rates in
Florida in future studies could inform intervention strategies in other US
geographic regions.
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Table 2
Independent variable OR 95% CI
Age, y 1.03 1.03–1.03
BMI 0.99 0.99–0.99
Sex
     Male 1.00 —
     Female 1.14 1.14–1.14
Education
     >High school 1.00 —
     High school 0.55 0.55–0.55
     <High school 0.44 0.44–0.44
Race
     Non-Hispanic white 1.00 —
     Non-Hispanic black 0.62 0.62–0.62
     Hispanic 0.46 0.46–0.46
     Other 0.48 0.47–0.48
Employment status
     Employed 1.00 —
     Unemployed 1.09 1.09–1.09
Health insurance status
     Insured 1.00 —
     Uninsured 0.65 0.65–0.65
Smoking status
     Nonsmoker 1.00 —
     Former 1.10 1.10–1.11
     Current 0.86 0.86–0.86
Drinking status
     Nondrinker 1.00 —
     Former 1.29 1.28–1.29
     Current 1.51 1.51–1.51
Compliant with Healthy People 2010 recommendations for physical exercise
     Yes 1.00 —
     No 0.69 0.69–0.69
Regional comparisons
     Florida 1.00 —
     Rest of South 0.75 0.75–0.75
     Northeast 0.84 0.84–0.84
     Midwest 0.53 0.53–0.53
     West 0.74 0.74–0.75
CI, confidence interval; OR, odds ratio.
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